GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Net Income (Continuing Operations)

RBC Bioscience (ROCO:6848) Net Income (Continuing Operations) : NT$6.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. RBC Bioscience's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was NT$4.1 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$6.4 Mil.

RBC Bioscience Net Income (Continuing Operations) Historical Data

The historical data trend for RBC Bioscience's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Net Income (Continuing Operations) Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial 14.46 141.90 28.73 3.78 6.43

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.78 8.51 -4.74 2.31 4.12

RBC Bioscience Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$6.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience  (ROCO:6848) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

RBC Bioscience Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Net Income (Continuing Operations)
Comparable Companies
ROCO:4197 ROCO:6744 ROCO:6864 ROCO:6662 ROCO:4131 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
Website
https://www.rbcbioscience.com
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines